Displaying 1-11 of 11 result(s).
| Board Name | Posts By Stevenvegas | Post Created |
|---|---|---|
| $We Beat Wallstreet | MIAMI - The winner of a roach-eatin | 10/09/2012 8:38:17 AM |
| $We Beat Wallstreet | We rich yet? :-) | 10/08/2012 7:40:15 PM |
| $We Beat Wallstreet | United States : Jobless Claims Prio | 04/05/2012 9:07:33 AM |
| $We Beat Wallstreet | Initial Jobless Claims 357K vs 355K | 04/05/2012 8:53:16 AM |
| $We Beat Wallstreet | Join us in daily live chat! http:// | 04/05/2012 8:16:38 AM |
| $We Beat Wallstreet | Opening day for Red Sox! | 04/05/2012 8:13:36 AM |
| $We Beat Wallstreet | Pumper! Bwaahahhaaaaa | 04/05/2012 8:13:20 AM |
| Penny Stock Millionaires | Wha the heck's goin on over here? : | 02/22/2012 6:14:42 PM |
| $We Beat Wallstreet | Fancy meeting you here lol | 02/22/2012 6:05:03 PM |
| $We Beat Wallstreet | We ride! As always! | 02/22/2012 2:12:56 PM |
| $We Beat Wallstreet | Welcome to post #1 of We Beat Walls | 02/22/2012 2:10:35 PM |
Recent Articles
- Promising Results for Rinatabart Sesutecan in Cancer Treatment
- Nuvalent Unveils Promising Insights on Neladalkib for ALK Cancer
- United Airlines Incident: Tarmac Collision at O'Hare Airport
- Samsung Chairman's Family Sells Shares to Meet Inheritance Tax
- Clinical Breakthrough: ITM's Promising Trial Results Unveiled
- Celcuity's Promising Phase 1 Trial Results on Prostate Cancer Therapy
- New Findings on Gedatolisib’s Efficacy for Advanced Breast Cancer
- Concerns Raised Over Elon Musk's Striking Compensation Package
- Qustodio: Elevating Digital Child Safety on iPhones in 2025
- Celcuity's Phase 3 VIKTORIA-1 Trial for PIK3CA Mutants Advances
- Innovative Gedatolisib and Darolutamide Study Shows Promise
- New Insights on Gedatolisib's Role in Breast Cancer Treatment
- Meta and Blue Owl Collaborate on $30 Billion AI Data Center
- Kura Oncology's Latest Insights on FTI Program Advancements
- Nvidia's Market Share Plummets: CEO Jensen Huang's Concerns
- Kura Oncology Unveils Promising Data from FTI Programs at ESMO
- Olema Oncology Shares Promising Findings on Palazestrant
- General Oncology's SHARON Trial Yields Encouraging Results
- Revitalizing ER+ Breast Cancer with Palazestrant and Ribociclib
- Corbus Pharmaceuticals Reports Promising Results for CRB-701
- Promising Data on NX-1607: A Breakthrough in Cancer Treatment
- Florida Cancer Specialists Revolutionizing Oncology Research
- Salesforce CEO's Apology Sparks Controversy in Tech Industry
- Significant Progress in Advanced Breast Cancer Treatments with Giredestrant
- Breakthrough in HPV Carcinoma Treatment by SCG Cell Therapy
- Innovative Immunotherapy SCG142 Shows Promise in Cancer Treatment
- Trump's Decision on Ukraine Missiles Revealed After Key Talks
- Kevin O'Leary Highlights Importance of American Dream for Leadership
- Transformational Program for Millennial Professionals Unveiled
- Investigation Launched as PeopleGuru Faces Data Breach Crisis
- Trump Seeks Supreme Court Approval for National Guard in Chicago
- Westhaven Gold Corp. Announces Executive Update and Future Plans
- Trump Commutes Santos' Prison Sentence Amid Public Support
- A New Toolkit to Enhance Executive Function Skills in Education
- Westhaven Gold Announces Leadership Changes and Operations Update
- Aeroméxico's Exciting Global Offering: What You Need to Know
- Investigation Into Luminar Technologies Signals Serious Concerns
- Inquiry into Hasbro Leadership: Legal Investigation Unfolds
- Legal Investigation of CVS/Aetna Medicare Advantage Claims
- Deadline Approaches for Dow Investors in Class Action Case
- Investors Alert: Key Class Action Lawsuit Against V.F. Corporation
- Fluor Corporation Lawsuit Update: Important Investor Info
- Investors Urged to Act Before KBR Class Action Deadline
- Cytokinetics Class Action Lawsuit Update: Important Deadlines
- Important Legal Update for WPP Investors: Key Deadline Approaches
- Molina Healthcare Faces Class Action Lawsuit Amid Financial Turmoil
- Marex Group Faces Class Action Lawsuit Over Financial Misconduct
- Lead the Charge: Join the Fly-E Group Securities Lawsuit
- Investigation into MoonLake Immunotherapeutics Raises Concerns
- MoonLake Immunotherapeutics: Investors Investigate Potential Fraud